Astrana Health delivered robust revenue of 956000000 in Q3 2025, doubling year-over-year, with Care Partners revenue of 897700000. Adjusted EBITDA was 68500000, up 52% YoY, while net income attributable to Astrana was 400000. GAAP EPS was 0.01 per share as the company integrated Prospect Health and continued scaling its platform. :contentReference[oaicite:0]{index=0}
Total revenue reached 956000000, up 100% from the prior year quarter. :contentReference[oaicite:1]{index=1}
Care Partners revenue was 897700000, up 97% YoY. :contentReference[oaicite:2]{index=2}
Adjusted EBITDA for the quarter was 68500000, up 52% YoY. :contentReference[oaicite:3]{index=3}
Net income attributable to Astrana was 400000 with EPS of 0.01. :contentReference[oaicite:4]{index=4}
Management updated full-year 2025 revenue guidance to $3.10B–$3.18B and adjusted EBITDA guidance to $200M–$210M, reflecting timing shifts in full-risk contract transitions rather than core performance issues. :contentReference[oaicite:5]{index=5}
Analyze how earnings announcements historically affect stock price performance